• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Autoimmune Drugs Market Size, Status and Forecast 2020-2026

report cover
  • 30 July 2020
  • Healthcare
  • 93 Pages
  • Report Code: 24LS-15844
  • Formate :   
Download FREE Report Sample Download PDF File

Autoimmune Drugs -MARKET ADVISORY SERVICES

Autoimmune Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter

Market segment by Type, the product can be split into
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Market segment by Application, split into
Hospitals
Homecare Settings
Specialty Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Drugs Revenue
1.4 Market by Type
1.4.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rheumatoid Arthritis (RA)
1.4.3 Multiple Sclerosis (MS)
1.4.4 Psoriasis
1.4.5 Inflammatory Bowel Disease (IBD)
1.4.6 Ankylosing Spondylitis (AS)
1.4.7 Systemic Lupus Erythematosus (SLE)
1.5 Market by Application
1.5.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Homecare Settings
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
2.2 Global Autoimmune Drugs Growth Trends by Regions
2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autoimmune Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Autoimmune Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Drugs Players by Market Size
3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Drugs Market Concentration Ratio
3.2.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
3.3 Autoimmune Drugs Key Players Head office and Area Served
3.4 Key Players Autoimmune Drugs Product Solution and Service
3.5 Date of Enter into Autoimmune Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Autoimmune Drugs Market Size by Application (2015-2020)
5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Autoimmune Drugs Market Size (2015-2020)
6.2 Autoimmune Drugs Key Players in North America (2019-2020)
6.3 North America Autoimmune Drugs Market Size by Type (2015-2020)
6.4 North America Autoimmune Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Autoimmune Drugs Market Size (2015-2020)
7.2 Autoimmune Drugs Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Drugs Market Size by Type (2015-2020)
7.4 Europe Autoimmune Drugs Market Size by Application (2015-2020)

8 China
8.1 China Autoimmune Drugs Market Size (2015-2020)
8.2 Autoimmune Drugs Key Players in China (2019-2020)
8.3 China Autoimmune Drugs Market Size by Type (2015-2020)
8.4 China Autoimmune Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Autoimmune Drugs Market Size (2015-2020)
9.2 Autoimmune Drugs Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Drugs Market Size by Type (2015-2020)
9.4 Japan Autoimmune Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2020)
10.2 Autoimmune Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)

11 India
11.1 India Autoimmune Drugs Market Size (2015-2020)
11.2 Autoimmune Drugs Key Players in India (2019-2020)
11.3 India Autoimmune Drugs Market Size by Type (2015-2020)
11.4 India Autoimmune Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Autoimmune Drugs Market Size (2015-2020)
12.2 Autoimmune Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Drugs Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Autoimmune Drugs Introduction
13.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Autoimmune Drugs Introduction
13.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
13.2.5 GSK Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Autoimmune Drugs Introduction
13.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Autoimmune Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Biogen
13.5.1 Biogen Company Details
13.5.2 Biogen Business Overview
13.5.3 Biogen Autoimmune Drugs Introduction
13.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
13.5.5 Biogen Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Autoimmune Drugs Introduction
13.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Autoimmune Drugs Introduction
13.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview
13.8.3 Roche Autoimmune Drugs Introduction
13.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Baxter
13.9.1 Baxter Company Details
13.9.2 Baxter Business Overview
13.9.3 Baxter Autoimmune Drugs Introduction
13.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
13.9.5 Baxter Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Autoimmune Drugs Key Market Segments

Table 2. Key Players Covered: Ranking by Autoimmune Drugs Revenue

Table 3. Ranking of Global Top Autoimmune Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Autoimmune Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Rheumatoid Arthritis (RA)

Table 6. Key Players of Multiple Sclerosis (MS)

Table 7. Key Players of Psoriasis

Table 8. Key Players of Inflammatory Bowel Disease (IBD)

Table 9. Key Players of Ankylosing Spondylitis (AS)

Table 10. Key Players of Systemic Lupus Erythematosus (SLE)

Table 11. Global Autoimmune Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 12. Global Autoimmune Drugs Market Size by Regions (US$ Million): 2020 VS 2026

Table 13. Global Autoimmune Drugs Market Size by Regions (2015-2020) (US$ Million)

Table 14. Global Autoimmune Drugs Market Share by Regions (2015-2020)

Table 15. Global Autoimmune Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 16. Global Autoimmune Drugs Market Share by Regions (2021-2026)

Table 17. Market Top Trends

Table 18. Key Drivers: Impact Analysis

Table 19. Key Challenges

Table 20. Autoimmune Drugs Market Growth Strategy

Table 21. Main Points Interviewed from Key Autoimmune Drugs Players

Table 22. Global Autoimmune Drugs Revenue by Players (2015-2020) (Million US$)

Table 23. Global Autoimmune Drugs Market Share by Players (2015-2020)

Table 24. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2019)

Table 25. Global Autoimmune Drugs by Players Market Concentration Ratio (CR5 and HHI)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players Autoimmune Drugs Product Solution and Service

Table 28. Date of Enter into Autoimmune Drugs Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 31. Global Autoimmune Drugs Market Size Share by Type (2015-2020)

Table 32. Global Autoimmune Drugs Revenue Market Share by Type (2021-2026)

Table 33. Global Autoimmune Drugs Market Size Share by Application (2015-2020)

Table 34. Global Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 35. Global Autoimmune Drugs Market Size Share by Application (2021-2026)

Table 36. North America Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 37. North America Key Players Autoimmune Drugs Market Share (2019-2020)

Table 38. North America Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 39. North America Autoimmune Drugs Market Share by Type (2015-2020)

Table 40. North America Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 41. North America Autoimmune Drugs Market Share by Application (2015-2020)

Table 42. Europe Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 43. Europe Key Players Autoimmune Drugs Market Share (2019-2020)

Table 44. Europe Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 45. Europe Autoimmune Drugs Market Share by Type (2015-2020)

Table 46. Europe Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 47. Europe Autoimmune Drugs Market Share by Application (2015-2020)

Table 48. China Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 49. China Key Players Autoimmune Drugs Market Share (2019-2020)

Table 50. China Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 51. China Autoimmune Drugs Market Share by Type (2015-2020)

Table 52. China Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 53. China Autoimmune Drugs Market Share by Application (2015-2020)

Table 54. Japan Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 55. Japan Key Players Autoimmune Drugs Market Share (2019-2020)

Table 56. Japan Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 57. Japan Autoimmune Drugs Market Share by Type (2015-2020)

Table 58. Japan Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 59. Japan Autoimmune Drugs Market Share by Application (2015-2020)

Table 60. Southeast Asia Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 61. Southeast Asia Key Players Autoimmune Drugs Market Share (2019-2020)

Table 62. Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 63. Southeast Asia Autoimmune Drugs Market Share by Type (2015-2020)

Table 64. Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 65. Southeast Asia Autoimmune Drugs Market Share by Application (2015-2020)

Table 66. India Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 67. India Key Players Autoimmune Drugs Market Share (2019-2020)

Table 68. India Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 69. India Autoimmune Drugs Market Share by Type (2015-2020)

Table 70. India Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 71. India Autoimmune Drugs Market Share by Application (2015-2020)

Table 72. Central & South America Key Players Autoimmune Drugs Revenue (2019-2020) (Million US$)

Table 73. Central & South America Key Players Autoimmune Drugs Market Share (2019-2020)

Table 74. Central & South America Autoimmune Drugs Market Size by Type (2015-2020) (Million US$)

Table 75. Central & South America Autoimmune Drugs Market Share by Type (2015-2020)

Table 76. Central & South America Autoimmune Drugs Market Size by Application (2015-2020) (Million US$)

Table 77. Central & South America Autoimmune Drugs Market Share by Application (2015-2020)

Table 78. Eli Lilly Company Details

Table 79. Eli Lilly Business Overview

Table 80. Eli Lilly Product

Table 81. Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 82. Eli Lilly Recent Development

Table 83. GSK Company Details

Table 84. GSK Business Overview

Table 85. GSK Product

Table 86. GSK Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 87. GSK Recent Development

Table 88. AbbVie Company Details

Table 89. AbbVie Business Overview

Table 90. AbbVie Product

Table 91. AbbVie Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 92. AbbVie Recent Development

Table 93. Johnson & Johnson Company Details

Table 94. Johnson & Johnson Business Overview

Table 95. Johnson & Johnson Product

Table 96. Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 97. Johnson & Johnson Recent Development

Table 98. Biogen Company Details

Table 99. Biogen Business Overview

Table 100. Biogen Product

Table 101. Biogen Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 102. Biogen Recent Development

Table 103. Amgen Company Details

Table 104. Amgen Business Overview

Table 105. Amgen Product

Table 106. Amgen Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 107. Amgen Recent Development

Table 108. Pfizer Company Details

Table 109. Pfizer Business Overview

Table 110. Pfizer Product

Table 111. Pfizer Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 112. Pfizer Recent Development

Table 113. Roche Business Overview

Table 114. Roche Product

Table 115. Roche Company Details

Table 116. Roche Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 117. Roche Recent Development

Table 118. Baxter Company Details

Table 119. Baxter Business Overview

Table 120. Baxter Product

Table 121. Baxter Revenue in Autoimmune Drugs Business (2015-2020) (Million US$)

Table 122. Baxter Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Autoimmune Drugs Market Share by Type: 2020 VS 2026

Figure 2. Rheumatoid Arthritis (RA) Features

Figure 3. Multiple Sclerosis (MS) Features

Figure 4. Psoriasis Features

Figure 5. Inflammatory Bowel Disease (IBD) Features

Figure 6. Ankylosing Spondylitis (AS) Features

Figure 7. Systemic Lupus Erythematosus (SLE) Features

Figure 8. Global Autoimmune Drugs Market Share by Application: 2020 VS 2026

Figure 9. Hospitals Case Studies

Figure 10. Homecare Settings Case Studies

Figure 11. Specialty Clinics Case Studies

Figure 12. Autoimmune Drugs Report Years Considered

Figure 13. Global Autoimmune Drugs Market Size YoY Growth 2015-2026 (US$ Million)

Figure 14. Global Autoimmune Drugs Market Share by Regions: 2020 VS 2026

Figure 15. Global Autoimmune Drugs Market Share by Regions (2021-2026)

Figure 16. Porter's Five Forces Analysis

Figure 17. Global Autoimmune Drugs Market Share by Players in 2019

Figure 18. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2019

Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Drugs Revenue in 2019

Figure 20. North America Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Europe Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. China Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Japan Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Southeast Asia Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. India Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Central & South America Autoimmune Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. Bottom-up and Top-down Approaches for This Report

Figure 28. Data Triangulation

Figure 29. Key Executives Interviewed

Eli Lilly

GSK

AbbVie

Johnson & Johnson

Biogen

Amgen

Pfizer

Roche

Baxter

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase